Financial statements Nowa Med
Balance sheet data of NOWA MED
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|---|---|---|---|---|---|---|
Total assets | 1 147 780,63 | 1 214 908,52 | 1 507 051,44 | 1 484 450,56 | 1 457 759,98 | 959 238,68 | 923 927,98 |
A. Fixed assets | 808 212,20 | 782 612,35 | 759 762,35 | 736 912,35 | 714 062,35 | 691 212,35 | 668 362,35 |
B. Current assets | 339 568,43 | 432 296,17 | 747 289,09 | 747 538,21 | 743 697,63 | 268 026,33 | 255 565,63 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 1 147 780,63 | 1 214 908,52 | 1 507 051,44 | 1 484 450,56 | 1 457 759,98 | 959 238,68 | 923 927,98 |
A. Equity | 16 788,11 | 28 958,73 | 35 391,58 | 41 446,16 | -31 712,87 | 71 371,65 | 50 145,22 |
B. Liabilities and provisions for liabilities | 1 130 992,52 | 1 185 949,79 | 1 471 659,86 | 1 443 004,40 | 1 489 472,85 | 887 867,03 | 873 782,76 |
I. Long-term liabilities | 994 392,00 | 1 092 458,26 | 1 379 297,35 | 1 337 318,02 | 1 379 380,91 | 841 927,04 | 826 987,77 |
II. Short-term liabilities | 136 600,52 | 93 491,53 | 92 362,51 | 105 686,38 | 110 091,94 | 45 939,99 | 46 794,99 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.